CD8A and neoplasm: Avasimibe, as an acyl-CoA acyltransferase inhibitor, prevents cholesterol esterification and enhances the level of intracellular free cholesterol tumor cells, thus inhibiting the proliferation and metastasis in tumor cells and increasing the activity of CD8+ T cells.